U.S. Markets closed

An Update on Johnson & Johnson’s Immunology Business

Daniel Collins
An Update on Johnson & Johnson’s Immunology Business

In the first quarter, Johnson & Johnson’s (JNJ) Immunology business generated revenues of $3.0 billion compared to $2.9 billion in the first quarter of 2017, which reflected ~3.8% YoY (year-over-year) growth.